Morgan Stanley’s chief China economist sees green shoots in China thanks to innovation, but highlights need for social security reform
Morgan Stanley’s chief China economist sees green shoots in China thanks to innovation, but highlights need for social ...
Morgan Stanley Cuts PBF Energy (NYSE:PBF) Price Target to $28.00
PBF Energy (NYSE:PBF – Free Report) had its price objective lowered by Morgan Stanley from $31.00 to $28.00 in a research ...
Morgan Stanley’s auto analyst polls his clients on what they think of Elon Musk—the results make for grim reading
Musk’s political activism either had a “negative” or “extremely negative” effect on Tesla’s business, according to 85% of ...
Morgan Stanley's Chief Strategist Issues Stock Market Warning
Mike Wilson, the firm's chief investment officer, predicted a slump for U.S. equities in the first half of 2025.
Morgan Stanley’s top quality stocks to own for the long term
Discover Morgan Stanley's 30 for 2027 top stock picks for long-term growth, focusing on sustainability, quality, and ...
Morgan Stanley’s Dim US Dollar Outlook Gets Darker as Economic Risks Mount
The dollar is already having its worst start to a year since the global financial crisis triggered a US recession, and Morgan ...
NDTV Profit4h
Coforge, IndiGo Replace Infosys And M&M In Morgan Stanley's 10-Stock Watchlist
Coforge offers a compelling growth story with scalability potential, while IndiGo enjoys strong cost advantage over peers, ...
Morgan Stanley Cuts UiPath (NYSE:PATH) Price Target to $12.00
UiPath (NYSE:PATH – Free Report) had its price target decreased by Morgan Stanley from $16.00 to $12.00 in a report published ...
Citi snags AI leader from Morgan Stanley to help turn around its wealth tech
Citi's poor technology is well known on Wall Street, but wealth boss CEO Andy Seig hopes to gain ground with this new hire ...
Here’s the level that could be an attractive entry point for stocks, says Morgan Stanley’s Mike Wilson
A Morgan Stanley analyst identifies the point where investors might find an attractive entry point to get back in the market.
2seventy Bio price target lowered to $5 from $6 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on 2seventy Bio (TSVT) to $5 from $6 and keeps an Equal Weight rating on the shares following ...